DOE Human Subjects Resources
Arlene Lennox, Medical Physicist at Fermilab, Retires.
Arlene Lennox, as Technical Director, has been at the heart of the Fermilab Neutron Therapy Facility for two decades. (http://www.niu.edu/PubAffairs/RELEASES/2004/dec/neutrons/bios.shtml) Since its opening in 1976 the Facility has treated more than 3,000 cancer patients. Clinical trials were conducted at Fermilab for 10 years to determine which cancers could be treated effectively by fast neutron therapy. (http://www.kcchronicle.com/articles/2008/02/03/news/local/doc47a55fffef3cc372551883.t)
Arlene Lennox celebrated her retirement from Fermilab on April 10, 2008. A farewell reception was held at Fermilab in spite of rain, fog, detours, and 40-mph winds. There were about 100 friends and colleagues present at her “cake and coffee” affair on the 2nd Floor Crossover at the laboratory. Bruce Chrisman, Chief Operating Officer, gave an introduction and brief history of Dr. Lennox’s career and accomplishments at the Fermilab Neutron Therapy Facility. Charles Pietri, DOE Human Subjects Working Group member, extended the best wishes for Dr. Lennox’s retirement from the Office of Science and especially from Elizabeth (Libby) White, DOE Human Subjects Protection Program Manager, and Peter Kirchner, Senior Scientific Advisor, in addition to those of the Working Group and friends and colleagues. Debra Marcantonio, Human Subjects Coordinator from the DOE Chicago Office and members of the DOE Fermi Site Office were also present. The dedication of Arlene Lennox to the protection of human subjects in her work at the Fermilab Neutron Therapy Facility over the past 20 years was noted. A gift (an engraved crystal bowl) was presented to Dr. Lennox as a small token of appreciation with the inscription: Leadership and Dedication. Human Subjects Protection
It was apparent that Dr. Lennox, as she read the gift card out loud, was pleased with both the thoughts expressed and with the gift.
Content reviewed: November 12, 2013